Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating a combination of melphalan, arsenic trioxide, and ascorbic acid in relapsed or refractory multiple myelo…
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple Myeloma [Phase 1]
This document summarizes a completed Phase 1 study of JNS002 (doxorubicin hydrochloride liposome injection) in relapsed or refractory multip…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy [Phase 3]
This Phase 3 trial evaluated epoetin alfa for treating anemia in patients with lymphoma, chronic lymphocytic leukemia, or multiple myeloma w…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 dose-escalation study of TAK-901 in subjects with advanced hematologic malignancies; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant [Phase 3]
Phase 3 clinical trial update evaluating lenalidomide in patients with multiple myeloma undergoing autologous stem cell transplantation; res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant [Phase 3]
Phase 3 clinical trial update evaluating lenalidomide in patients with multiple myeloma undergoing autologous stem cell transplant; status A…
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 trial update evaluating the combination of chemotherapy and bone marrow transplantation in patients with leukemia or myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) [Phase 4]
This Phase 4 clinical trial update evaluates the safety and efficacy of busulfan as a conditioning regimen prior to hematopoietic cell trans…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating interferon alfa after chemotherapy and peripheral stem cell transplantation in patients with Stage III or …
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma [Phase 1]
Phase 1 trial update evaluating GCS-100LE for multiple myeloma has been terminated; the report covers safety and potential efficacy findings…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer [Phase 1]
A Phase 1 clinical trial update reports completion of arsenic trioxide in patients with advanced hematologic cancers, including leukemia and…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial update evaluating bevacizumab with or without thalidomide in relapsed or refractory multiple myeloma; the s…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluated combining MAGE-A3 and NY-ESO-1 immunotherapies with DTPACE chemotherapy and autologous transp…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer [Phase 2]
Phase 2 clinical trial update examining the combination of phenylbutyrate and azacitidine in patients with acute myeloid leukemia, myelodysp…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Interleukin-12 in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating interleukin-12 in patients with multiple myeloma has completed.
-
CLINICAL_TRIALS withdrawal · 2013-06-21Clinical Trial Update: Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma [Phase 2]
This document reports that a Phase 2 trial of autologous stem cell transplantation with maintenance therapy for multiple myeloma has been te…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer [Phase 1]
This clinical trial update reports the Phase 1 safety and tolerability results of PCI-24781 in cancer patients. The study, sponsored by Phar…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma [Phase 2]
Phase 2 trial update evaluating melphalan and filgrastim to stimulate peripheral stem cell collection in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: PS-341 in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial update of PS-341 (bortezomib) in hematologic cancers; the study has completed and includes leukemia, lymphoma, multiple myelom…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation [NA]
This completed clinical trial evaluated whether music therapy reduces pain and emotional distress in patients with hematologic cancers under…
-
FDA approval · 2013-06-17FDA Approved: CYCLOPHOSPHAMIDE — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for cyclophosphamide from Civica, Inc. under ANDA 040745.
-
CLINICAL_TRIALS research · 2013-06-06Clinical Trial Update: A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma [Phase 4]
Phase 4 clinical trial comparing PAD versus Velcade, Cyclophosphamide and Dexamethasone (VCD) in multiple myeloma; current status is unknown…
-
FDA approval · 2013-06-04FDA Approved: MOZOBIL — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for MOZOBIL (plerixafor) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS research · 2013-06-04Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma [Phase 1, Phase 2]
A clinical trial update describing a Phase 1/2 study of PRLX 93936 in multiple myeloma, focusing on safety, efficacy, and pharmacokinetics.
-
CLINICAL_TRIALS research · 2013-06-04Clinical Trial Update: Evaluating the Efficacy and Safety of the Lower Dose of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation- KMM103 Study [Phase 1, Phase 2]
This clinical trial update outlines evaluation of a lower-dose conditioning regimen consisting of bortezomib with busulfan and melphalan in …